DEMO S.A. Pharmaceutical Industry is an industrial and commercial organization established in 1965 and active in the production and sales of pharmaceutical products.
During the past years, DEMO S.A. has achieved a significant growth in all its business segments. This growth has enabled us to achieve results that are a testament to the quality and dedication of our employees.
- Ranked #1 in production facilities for injectables in Greece
- Ranked #1 in hospital sales (in terms of sold units) and exports of branded products in Greece
- Within the Top 100 Greek industries
- Ranked #1 company in private funds invested in Greece
- Ranked #1 in new jobs creation in Greece
- Within the Top 200 Companies in new jobs creation in the European Union
- Official Supplier of the United Nations
- Official Supplier of UNICEF
- Official Supplier of World Health Organization
- Official Supplier of Medicines Sans Frontiers
- Official Supplier of International Committee of the Red Cross
Official Supplier of the United Nations
Within the Top 100 Greek industries
Within the Top 200 Companies in new jobs creation in the European Union
Official Supplier of UNICEF
DEMO S.A. Pharmaceutical Industry is an industrial and commercial organization established in 1965 and active in the production and sales of pharmaceutical products.
We are one of the major pharmaceutical manufacturers in Greece with a very strong presence in the hospital market, ranking first among all the Greek pharmaceutical companies in terms of units sold.
Our product portfolio includes many injectable generic pharmaceutical formulations from several therapeutic categories including: Injectable products of all forms such us Liquid injectables in glass ampoules, vials & bottles, sterile powders and freeze – dried formulations, Lyophilised products, Emulsions, Penems, Penicillins, Cephalosporins).
DEMO S.A. is currently active across 96 countries (as of 31/05/2016), including countries in Europe, Asia, Africa, Latin America, Oceania & the Middle East.
Hospital Market
Anti-infectives
- Non-beta lactams
- Cephalosporins
- Carbapenems
- Penicillins
- Antiviral
Standard solutions
Anesthesia/analgesia
Oncology
Critical care
Parenteral nutrition
Gastric ulcers & GORD
Hematology
Antithrombotic
Anti-inflammatory
Respiratory
Central nervοus system (CNS)
Miscellaneous
Medical Devices/ Infusion Pumps
Renal Care
DEMO S.A. started producing its first dialysisproducts in 1996 via a complete range of haemodialysis solutions.
In 1997 our company started distributing the products of a major manufacturer of medical devices for haemodialysis. We concluded an agreement to exclusively distribute their products in Greece, including, but not limited to, haemodialysismachines, haemodialysis filters, fistula needles,catheters, haemostatic pressure bandages & blood lines.
During 2005, our company completed the registration and started manufacturing three haemodiafiltration solutions. In parallel, DEMO is taking all necessary actions for the entrance of the company in the market of peritoneal dialysis. The above activities have placed DEMO S.A. as one of the biggest players in the area of renal services in Greece.
Private Market
RX Products
- GPs
- Cardiology
- Oncology
- Respiratory
- Gastroenterology
- Urology
- Hematology
- Rheumatology
- Ophthalmic
Medical Devices
- Solutions for contact lenses
- Solutions for eye care
- Cleaning Solutions for ears and nose
- Spray and Solutions for wound care
- Irrigation solutions
Food Supplements
- For the Urinary System
- For Liver Health
- For Respiratory health
- For Diabetes management
- For Cardiovascular health
- Food supplement range for children
Ranked #1 in production facilities for injectables in Greece
No1 company in private funds invested in Greece
No1 in new jobs creation in Greece
Ranked #1 in hospital sales (in terms of sold units) and exports of branded products in Greece
Our company’s Sales and Marketing Departments employ well trained and highly specialized staff. We have a daily presence in all hospital institutions of the country, both public (hospitals) and private (hospitals and clinics).
Our Hematology Department (H.B.U.) promotes pharmaceutical products unique in their category, for example for the treatment of rare hemoglobinopathies, such as thalassemia and sickle cell disease:
- Ferriprox (deferiprone)
- Siklos (hydroxycarbamide)
Our company started producing its first renal products in 1996 via a complete range of hemodialysis solutions.
In parallel, it supplies the Greek market with dialysers, catheters, blood lines and dialysis machines.
Binocrit (epoetin-alfa) and Zarzio (filgrastim) are included in Oncology portfolio of our company. Both products are biosimilars and are part of our collaboration with Sandoz, a division of the Novartis Group.
The Oncology portfolio also includes Zoxalon (zoledronic acid), the chemotherapy (Cytototoxic) drugs DEMOZAR (gemcitabine) and Irinocan (irinotecan) and the biological agent Ιmatinib DEMO.’’
Our company currently provides hospital institutions with unique and irreplaceable products, such as Adrenaline and other products assigned directly from EOF.
We also offer a wide range of saline solutions and ampoules.
We provide the Private Market with general medicine, cardiology, oncology, respiratory, gastroenterology, urology, hematology, rheumatology and ophthalmic products.
We offer a complete range of antibiotic products for the efficient treatment of infections in hospitals.
Our vision is to provide quality, as well as reliable and innovative pharmaceutical products worldwide.
Our goal is to be consistently one of the best companies in the pharmaceutical market, maintaining our leadership position in the Greek industry, the positive growth rate and the preference of our customers and partners that is based on their confidence for the products we produce.
DEMO intends to remain on top of the Greek pharmaceutical industry while further establishing its position as one of the leading manufacturing companies worldwide.
Having already achieved rapid growth in the global generics pharmaceutical market, we aim to contribute with innovative, quality products and services, improving the lives of patients worldwide and ensuring the steady confidence of our customers. Our modern and fully equipped manufacturing premises, the advanced technologies that we have adopted, our constant product portfolio expansion and our international presence are the means to the end.
Therefore, we have invested strongly in the creation and sourcing of our state-of-the-art Research & Development laboratory. DEMO’s R&D lab spans more than, 4.000 m2 it is equipped with the latest instruments and is staffed with the top graduates of the University of Athens. Under the supervision of highly qualified researchers – most of whom own PhD degrees from the most acclaimed universities in Europe – our R&D lab represents the company’s launching pad for the future!